Changes Implementing Nucleotide and/or Amino Acid Sequence Listings
The Patent and Trademark Office (PTO) is proposing to amend the rules for submitting nucleic acid or amino acid sequences in computer readable form (CRF) for patent applications to simplify the requirements of the rules, to rearrange portions of the rules for better understanding and to establish consistent rules to permit a single internationally acceptable computer readable form. The Sequence Listing will be presented in an international, language neutral format using numeric identifiers rather than the current subject headings and the paper Sequence Listing will be a separately numbered section of the patent application. Sequences which contain fewer than four (4) specifically identified nucleotides or amino acids will no longer be required to be submitted in computer readable form.
- Task
- Read the news
- Patent or trademark
- both
- Legacy system
- —
- Current entry point
- www.federalregister.gov/documents/1996/10/04/96-25074/changes-implementing-nucleotide-andor-amino-acid-sequence-listings (permanent link in the Federal Register, verified 2026-09-30)
- Legacy system and where it moved
- No legacy system name mention in title or summary )
- Fee
- No fee mention in title or summary )
- What you need (account or API key)
- No account or key mention in title or summary )
- Published
- 1996-10-04
- Document type
- Proposed Rule
- Source
- USPTO documents published in the Federal Register (Federal Register API)(retrieved 2026-10-06)
Everything in the same category
Read the news (all 1988) · both (all 2333)
Related entry points
- Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Disclosures
- Standard for Presentation of Nucleotide and Amino Acid Sequence Listings Using XML (eXtensible Markup Language) in Patent Applications To Implement WIPO Standard ST.26; Incorporation by Reference
- Standard for Presentation of Nucleotide and Amino Acid Sequence Listings Using eXtensible Markup Language (XML) in Patent Applications To Implement WIPO Standard ST.26; Incorporation by Reference
- Standard ST.26-Request for Comments on the Recommended Standard for the Presentation of Nucleotide and Amino Acid Sequence Listings Using XML (eXtensible Markup Language)
- Electronic Submission of a Sequence Listing, a Large Table, or a Computer Program Listing Appendix in Patent Applications
- Adoption of Updated WIPO Standard ST.26; Revision to Incorporation by Reference
- Adoption of Updated WIPO Standard ST.26; Revision to Incorporation by Reference
- Electronic Submission of a Sequence Listing, a Large Table, or a Computer Program Listing Appendix in Patent Applications
- Request for Comments on the Recommendation for the Disclosure of Sequence Listings Using XML (Proposed ST.26)
- 1996 Changes to Patent Practice and Procedure
- Changes To Information Disclosure Statement Requirements and Other Related Matters
- Changes To Permit Delayed Submission of Certain Requirements for Prioritized Examination
- Changes To Practice for Continuing Applications, Requests for Continued Examination Practice, and Applications Containing Patentably Indistinct Claims
- Changes to Patent Practice and Procedure
- Pilot Program for Extended Time Period To Reply to a Notice To File Missing Parts of Nonprovisional Application
- Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Disclosures; Correction